Chosen among the top four from an impressive field of innovative healthtech companies, this milestone showcases the real-world impact and market readiness of their clinical-grade Altrais AI platform for OCT scan analysis.
By detecting 70+ retinal biomarkers, Altris AI empowers eye care professionals with objective insights to improve diagnosis, treatment decisions, and patient outcomes.
By detecting 70+ retinal biomarkers, Altris AI empowers eye care professionals with objective insights to improve diagnosis, treatment decisions, and patient outcomes.